SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories - Quaterly Results

29 Jul 2022 Evaluate
Net sales declined -24.87%  to  Rs. 2743.97 million from Rs. 3652.31 millions.The company suffered a huge decline of -77.71% to Rs. 68.75  millions from Rs. 308.47 millions  of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 143.18 millions from 442.26 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 2743.97 3652.31 -24.87 2743.97 3652.31 -24.87 14492.67 11124.23 30.28
Other Income 7.09 15.83 -55.21 7.09 15.83 -55.21 102.35 117.74 -13.07
PBIDT 143.18 442.26 -67.63 143.18 442.26 -67.63 1393.72 1241.47 12.26
Interest 3.95 2.11 87.20 3.95 2.11 87.20 -73.66 17.88 -511.97
PBDT 139.23 440.15 -68.37 139.23 440.15 -68.37 1467.38 1223.59 19.92
Depreciation 43.71 53.96 -19.00 43.71 53.96 -19.00 211.95 281.10 -24.60
PBT 95.52 386.19 -75.27 95.52 386.19 -75.27 1255.43 942.49 33.20
TAX 26.77 77.72 -65.56 26.77 77.72 -65.56 244.81 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 24.83 0.00 0.00
PAT 68.75 308.47 -77.71 68.75 308.47 -77.71 1010.62 942.49 7.23
Equity 998.27 899.59 10.97 998.27 899.59 10.97 955.59 899.59 6.23
PBIDTM(%) 5.22 12.11 -56.91 5.22 12.11 -56.91 9.62 11.16 -13.83

Morepen Laboratories Share Price

41.92 0.79 (1.92%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×